145 related articles for article (PubMed ID: 3731144)
1. Intrinsic versus acquired drug resistance.
Mackillop WJ
Cancer Treat Rep; 1986 Jun; 70(6):817-8. PubMed ID: 3731144
[No Abstract] [Full Text] [Related]
2. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.
Goldie JH; Coldman AJ
Cancer Treat Rep; 1979; 63(11-12):1727-33. PubMed ID: 526911
[TBL] [Abstract][Full Text] [Related]
3. [Drug resistance in malignant neoplasms].
Czownicki Z
Pol Tyg Lek; 1982 Apr; 37(6):173-5. PubMed ID: 7122313
[No Abstract] [Full Text] [Related]
4. [Resistance and resistances].
Cappelaere P
Bull Cancer; 1994 Dec; 81 Suppl 2():115s-117s. PubMed ID: 7727857
[TBL] [Abstract][Full Text] [Related]
5. Quantitative model for multiple levels of drug resistance in clinical tumors.
Goldie JH; Coldman AJ
Cancer Treat Rep; 1983 Oct; 67(10):923-31. PubMed ID: 6627236
[TBL] [Abstract][Full Text] [Related]
6. [Multidrug resistance].
Donenko FV; Sitdikova SM; Moroz LV
Vopr Onkol; 1991; 37(7-8):780-8. PubMed ID: 1842629
[No Abstract] [Full Text] [Related]
7. Drug resistance modulation in the laboratory and the clinic.
Dalton WS
Semin Oncol; 1993 Feb; 20(1):64-9. PubMed ID: 8475411
[No Abstract] [Full Text] [Related]
8. First Annual Pezcoller Symposium. Drug resistance--mechanisms and reversal.
Mihich E
Cancer Res; 1989 Dec; 49(24 Pt 1):7168-71. PubMed ID: 2582457
[No Abstract] [Full Text] [Related]
9. Human tumor stem-cell clonogenic assay--another failed cancer fad?
Hall TC
Hawaii Med J; 1984 Oct; 43(10):374-8. PubMed ID: 6511386
[No Abstract] [Full Text] [Related]
10. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
11. [Resistance, the cause of failure in antineoplastic chemotherapies].
Israel L
Pathol Biol (Paris); 1989 Feb; 37(2):125-7. PubMed ID: 2652060
[No Abstract] [Full Text] [Related]
12. Multiple drug resistance in cancer therapy.
Schneider E; Cowan KH
Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772
[No Abstract] [Full Text] [Related]
13. The human tumor colony forming assay: review and clinical applications.
Triedman JK; Witman GB; Chee DO; Triedman LJ
R I Med J (1976); 1985 Aug; 68(8):361-6. PubMed ID: 3863223
[No Abstract] [Full Text] [Related]
14. [In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder].
Anton-Aparicio LM; Urmeneta J; Borras M; Balaguer R; Berián JM
Actas Urol Esp; 1985; 9(6):517-22. PubMed ID: 3938597
[No Abstract] [Full Text] [Related]
15. Transcription factors and drug resistance.
Kohno K; Uchiumi T; Niina I; Wakasugi T; Igarashi T; Momii Y; Yoshida T; Matsuo K; Miyamoto N; Izumi H
Eur J Cancer; 2005 Nov; 41(16):2577-86. PubMed ID: 16209921
[TBL] [Abstract][Full Text] [Related]
16. Calculated resistance in cancer.
Sawyers CL
Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
[No Abstract] [Full Text] [Related]
17. Human tumor stem cell clonogenic assay sensitivity in malignant tumors and clinical correlation.
Banerjee TK; Marx JJ; Spencer SK; Tiffany E
Wis Med J; 1982 Dec; 81(12):19-22. PubMed ID: 6760565
[No Abstract] [Full Text] [Related]
18. [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].
González-Manzano R
Med Clin (Barc); 1994 Apr; 102(13):506-15. PubMed ID: 7911549
[No Abstract] [Full Text] [Related]
19. Use of the human tumor stem cell assay to study chemotherapy sensitivity in cancer of the cervix.
Parker RL; Welander CE; Homesley HD; Jobson VW; Kawamoto EH
Obstet Gynecol; 1984 Sep; 64(3):412-6. PubMed ID: 6462571
[TBL] [Abstract][Full Text] [Related]
20. [Development of antitumor agents: retrospection and perspective].
Sakurai Y
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1087-93. PubMed ID: 6870293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
